{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:41:10Z","timestamp":1790743270331,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec>\n            <jats:title>Background and Purpose<\/jats:title>\n            <jats:p>\n                                 <jats:sup>18<\/jats:sup>F-PBR06 and <jats:sup>11<\/jats:sup>C-PBR28 are second-generation PET radioligands targeting the 18-kd translocator protein to assess microglial activation. We directly compared <jats:sup>18<\/jats:sup>F-PBR06 and <jats:sup>11<\/jats:sup>C-PBR28 for detecting brain translocator protein binding in multiple sclerosis (MS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Six patients with MS (4 women; mean age \u00b1 SD, 32.1 \u00b1 4.9 [range, 23.5\u201337.4 years]; Expanded Disability Status Scale score 2.3 \u00b1 1.2 [range, 1.0\u20134.0]) underwent brain PET with both ligands, along with 3-T MRI. MRI was coregistered to the summed 60- to 90-minute PET images. SUV ratios (SUVRs), derived by normalization to global brain radioactivity, were obtained for whole-brain white matter (WM), supratentorial WM, normal-appearing WM (NAWM), and T2 (fluid-attenuated inversion recovery) hyperintense and T1 hypointense MS WM lesions. The highest mean SUVR for the fluid-attenuated inversion-recovery lesional slices was defined as SUVRmax.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>\n                                 <jats:sup>18<\/jats:sup>F-PBR06 and <jats:sup>11<\/jats:sup>C-PBR28 were moderately intercorrelated for whole-brain WM SUVR (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.83, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04) and supratentorial WM SUVR (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.81, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.05) but not for SUVRs of NAWM, T1 lesions, T2 lesions, or SUVRmax. Both tracers demonstrated that SUVR was higher in NAWM than in T1 and T2 lesions (all <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). <jats:sup>18<\/jats:sup>F-PBR06 (but not <jats:sup>11<\/jats:sup>C-PBR28) demonstrated a higher SUVR in T1 versus T2 lesions (0.85 \u00b1 0.07 vs 0.78 \u00b1 0.03, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03). <jats:sup>18<\/jats:sup>F-PBR06-derived (but not <jats:sup>11<\/jats:sup>C-PBR28) SUVRmax correlated with both Expanded Disability Status Scale score (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.82, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04) and timed 25-ft walking speed (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.89, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our preliminary results suggest an association between microglial activation and physical disability in MS. Microglial detection in lesions was not interchangeable between the tracers, with a higher clinical relevance suggested for <jats:sup>18<\/jats:sup>F-PBR06.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000002179","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T01:31:11Z","timestamp":1531531871000},"page":"e289-e295","source":"Crossref","is-referenced-by-count":27,"title":["18F-PBR06 Versus 11C-PBR28 PET for Assessing White Matter Translocator Protein Binding in Multiple Sclerosis"],"prefix":"10.1097","volume":"43","author":[{"given":"Tarun","family":"Singhal","sequence":"first","affiliation":[{"name":"Partners Multiple Sclerosis Center, Laboratory for Neuroimaging Research, Ann Romney Center for Neurological Diseases, Department of Neurology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"O'Connor","sequence":"additional","affiliation":[{"name":"Partners Multiple Sclerosis Center, Laboratory for Neuroimaging Research, Ann Romney Center for Neurological Diseases, Department of Neurology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipra","family":"Dubey","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Belanger","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Hurwitz","sequence":"additional","affiliation":[{"name":"Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renxin","family":"Chu","sequence":"additional","affiliation":[{"name":"Partners Multiple Sclerosis Center, Laboratory for Neuroimaging Research, Ann Romney Center for Neurological Diseases, Department of Neurology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahamat","family":"Tauhid","sequence":"additional","affiliation":[{"name":"Partners Multiple Sclerosis Center, Laboratory for Neuroimaging Research, Ann Romney Center for Neurological Diseases, Department of Neurology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie F.","family":"Kijewski","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo F.","family":"DiCarli","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L.","family":"Weiner","sequence":"additional","affiliation":[{"name":"Partners Multiple Sclerosis Center, Laboratory for Neuroimaging Research, Ann Romney Center for Neurological Diseases, Department of Neurology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21640","article-title":"The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?","volume":"65","year":"2009","journal-title":"Ann Neurol"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1172\/JCI90609","article-title":"CNS inflammation and neurodegeneration","volume":"127","year":"2017","journal-title":"J Clin Invest"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/brain\/awu331","article-title":"Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome","volume":"138","year":"2015","journal-title":"Brain"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1212\/WNL.0b013e3182635645","article-title":"Increased PK11195 PET binding in the cortex of patients with MS correlates with disability","volume":"79","year":"2012","journal-title":"Neurology"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1352458516674568","article-title":"Imaging of microglial activation in MS using PET: research use and potential future clinical application","volume":"23","year":"2017","journal-title":"Mult Scler"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00259-010-1622-y","article-title":"Comparison of 18F- and 11C-labeled aryloxyanilide analogs to measure translocator protein in human brain using positron emission tomography","volume":"38","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2967\/jnumed.109.068064","article-title":"Biodistribution and radiation dosimetry in humans of a new PET ligand, (18)F-PBR06, to image translocator protein (18 kDa)","volume":"51","year":"2010","journal-title":"J Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ana.24791","article-title":"Neuroinflammatory component of gray matter pathology in multiple sclerosis","volume":"80","year":"2016","journal-title":"Ann Neurol"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/brain\/awt145","article-title":"In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease","volume":"136","year":"2013","journal-title":"Brain"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.rcl.2004.08.010","article-title":"Quantification in PET","volume":"42","year":"2004","journal-title":"Radiol Clin North Am"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.2967\/jnumed.116.187161","article-title":"11C-PBR28 and 18F-PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis","volume":"58","year":"2017","journal-title":"J Nucl Med"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13550-016-0226-3","article-title":"Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer's disease","volume":"6","year":"2016","journal-title":"EJNMMI Res"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40120-016-0054-4","article-title":"The effect of dimethyl fumarate on cerebral gray matter atrophy in multiple sclerosis","volume":"5","year":"2016","journal-title":"Neurol Ther"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/00207454.2017.1283313","article-title":"Sample size requirements for one-year treatment effects using deep gray matter volume from 3 T MRI in progressive forms of multiple sclerosis","volume":"127","year":"2017","journal-title":"Int J Neurosci"},{"key":"bib16-20230925","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(02)00425-2","article-title":"A semiautomated measure of whole-brain atrophy in multiple sclerosis","volume":"208","year":"2003","journal-title":"J Neurol Sci"},{"key":"bib17-20230925","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3174\/ajnr.A3083","article-title":"The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis","volume":"33","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib18-20230925","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","year":"2002","journal-title":"Neuroimage"},{"key":"bib19-20230925","article-title":"[F-18]PBR06 PET to assess TSPO binding and its association with brain atrophy and disability in multiple sclerosis"},{"key":"bib20-20230925","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/B978-0-444-52001-2.00002-9","article-title":"Pathology of multiple sclerosis and related inflammatory demyelinating diseases","volume":"122","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"bib21-20230925","first-page":"156","article-title":"Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation","volume":"9","year":"2012","journal-title":"J Neuroinflammation"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","article-title":"An updated histological classification system for multiple sclerosis lesions","volume":"133","year":"2017","journal-title":"Acta Neuropathol"},{"key":"bib23-20230925","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2967\/jnumed.113.131698","article-title":"In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand 1 1C-PK11195","volume":"55","year":"2014","journal-title":"J Nucl Med"},{"key":"bib24-20230925","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2967\/jnumed.113.135129","article-title":"In vivo assessment of brain white matter inflammation in multiple sclerosis with (18)F-PBR111 PET","volume":"55","year":"2014","journal-title":"J Nucl Med"},{"key":"bib25-20230925","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ejrad.2015.05.004","article-title":"MRI detection of hypointense brain lesions in patients with multiple sclerosis: T1 spin-echo vs. gradient-echo","volume":"84","year":"2015","journal-title":"Eur J Radiol"},{"key":"bib26-20230925","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00415-015-8009-8","article-title":"An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis","volume":"263","year":"2016","journal-title":"J Neurol"},{"key":"bib27-20230925","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/1531-8249(199911)46:5<747::AID-ANA10>3.0.CO;2-4","article-title":"Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability","volume":"46","year":"1999","journal-title":"Ann Neurol"},{"key":"bib28-20230925","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1093\/brain\/awf235","article-title":"Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time","volume":"125","year":"2002","journal-title":"Brain"},{"key":"bib29-20230925","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/jon.12433","article-title":"Characterizing clinical and MRI dissociation in patients with multiple sclerosis","volume":"27","year":"2017","journal-title":"J Neuroimaging"},{"key":"bib30-20230925","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ana.24497","article-title":"Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque","volume":"78","year":"2015","journal-title":"Ann Neurol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201809000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:06:49Z","timestamp":1695618409000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201809000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002179","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}